COMPANY
Magnetic Insight, Inc.
NIH awards 15
- NIH award 5R44EB035078-02 FY2024: $996,469 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Ultra-low distortion and noise electronic source ↗
- NIH award 5R44CA285064-02 FY2024: $1,012,220 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Development of a prototype clinical the source ↗
- NIH award 1R44EB035078-01 FY2023: $1,008,452 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Ultra-low distortion and noise electron source ↗
- NIH award 1R44CA285064-01 FY2023: $1,011,684 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Development of a prototype clinical the source ↗
- NIH award 5R44EB029877-02 FY2021: $802,387 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Color MPI as a novel method for in vivo a source ↗
- NIH award 1R44EB029877-01 FY2020: $809,897 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Color MPI as a novel method for in vivo a source ↗
- NIH award 5R44DA041814-03 FY2020: $759,415 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Phase II: Development of a Neurovascular source ↗
- NIH award 1R43CA233155-01A1 FY2019: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Development of a commercial Magnetic Pa source ↗
- NIH award 5R44EB020463-04 FY2019: $730,652 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Phase II: Commercialization of a preclini source ↗
- NIH award 2R44DA041814-02 FY2019: $1,066,136 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Phase II: Development of a Neurovascula source ↗
- NIH award 2R44EB020463-03 FY2018: $757,493 awarded for that fiscal year; activity R44 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Phase II: Commercialization of a preclini source ↗
- NIH award 5R43EB020463-02 FY2016: $348,285 awarded for that fiscal year; activity R43 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Commercialization of a preclinical Magnet source ↗
- NIH award 1R43DA041814-01A1 FY2015: $223,825 awarded for that fiscal year; activity R43 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Development of a Neurovascular Magnetic source ↗
- NIH award 3R43EB020463-01S1 FY2015: $31,356 awarded for that fiscal year; activity R43 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Commercialization of a preclinical Magne source ↗
- NIH award 1R43EB020463-01 FY2015: $348,285 awarded for that fiscal year; activity R43 (SBIR); PI GOODWILL, PATRICK; recipient as written: MAGNETIC INSIGHT, INC., Alameda, CA. Commercialization of a preclinical Magnet source ↗